He noted that the price reduction "is happening gradually."
The minister explained that “when it’s a small volume - one price, as soon as the volume increases plus favipiravir as a medical generic name is included in VED, price regulation by the state is automatically turned on”.
“It has now decreased by more than two times,” said Manturov.
He added that "this work will continue further as production increases."
Earlier it was reported that the Russian Ministry of Health updated the temporary recommendations for the treatment of coronavirus infection COVID-19, including "Favipiravir" in the list of antiviral drugs approved for outpatient use.